|
|
Volumn 367, Issue 22, 2012, Pages 2154-2156
|
|
Multidrug-resistant tuberculosis [1]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEDAQUILINE;
DELAMANID;
QUINOLONE DERIVATIVE;
RIFAMPICIN;
NITROIMIDAZOLE DERIVATIVE;
OXAZOLE DERIVATIVE;
TUBERCULOSTATIC AGENT;
COMBINATION CHEMOTHERAPY;
DRUG ANTAGONISM;
DRUG EFFICACY;
DRUG INDICATION;
DRUG MISUSE;
HEALTH CARE POLICY;
HUMAN;
LETTER;
MULTIDRUG RESISTANT TUBERCULOSIS;
PRIORITY JOURNAL;
TUBERCULOSIS CONTROL;
BACTERIAL TRANSMISSION;
CHINA;
HEALTH CARE PLANNING;
HOSPITAL INFECTION;
INFECTION CONTROL;
INFECTION PREVENTION;
INFECTION RISK;
PREVALENCE;
STRATEGIC PLANNING;
EPIDEMIC;
FEMALE;
MALE;
NOTE;
STATISTICS;
ANTITUBERCULAR AGENTS;
EPIDEMICS;
FEMALE;
HUMANS;
MALE;
NITROIMIDAZOLES;
OXAZOLES;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
|
|
EID: 84870003442
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1210001 Document Type: Letter |
|
Times cited : (8)
|
|
References (5)
|
